Alkynyl myristic acid

CAS No. 82909-47-5

Alkynyl myristic acid ( 13-Tetradecynoic acid; tetradec-13-ynoic acid; 13-Tetradecyn-1-oic acid )

Catalog No. M26602 CAS No. 82909-47-5

Alkynyl myristic acid is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 46 Get Quote
10MG 69 Get Quote
25MG 143 Get Quote
50MG 237 Get Quote
100MG 357 Get Quote
500MG 842 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Alkynyl myristic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Alkynyl myristic acid is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
  • Description
    Alkynyl myristic acid is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • Synonyms
    13-Tetradecynoic acid; tetradec-13-ynoic acid; 13-Tetradecyn-1-oic acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Antifungal
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    82909-47-5
  • Formula Weight
    224.3
  • Molecular Formula
    C14H24O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)CCCCCCCCCCCC#C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.I Kubo, et al. Polygodial, an antifungal potentiator. J Nat Prod. Jan-Feb 1988;51(1):22-9.
molnova catalog
related products
  • Hemicholinium-3(b)

    A potent inhibitor of the high affinity uptake system for CHOLINE. It has less effect on the low affinity uptake system.

  • Cyclo(Ser-Pro)

    From Pantoea agglomerans.

  • anemarsaponin B

    Anemarsaponin B has anti-inflammatory effect in LPS-treated RAW 264.7macrophages, the effect is associated with the inhibition of NF-κB transcriptional activity, possibly via the p38 MAP kinase pathway.